Total Payments
$19,335
2024 Payments
$1,750
Companies
61
Transactions
982
Medicare Patients
13,595
Medicare Billing
$1.9M
Payment Breakdown by Category
Food & Beverage$18,046 (93.3%)
Other$1,175 (6.1%)
Education$113.84 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,046 | 976 | 93.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,175 | 4 | 6.1% |
| Education | $113.84 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $1,634 | 40 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,546 | 107 | $0 (2024) |
| Amgen Inc. | $1,521 | 89 | $0 (2024) |
| Novo Nordisk Inc | $1,400 | 70 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,210 | 56 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,124 | 58 | $0 (2024) |
| Merck Sharp & Dohme LLC | $968.73 | 55 | $0 (2024) |
| Amarin Pharma Inc. | $829.75 | 40 | $0 (2023) |
| PFIZER INC. | $806.12 | 62 | $0 (2024) |
| Abbott Laboratories | $785.99 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,750 | 86 | Novo Nordisk Inc ($217.39) |
| 2023 | $1,975 | 97 | Novo Nordisk Inc ($184.54) |
| 2022 | $2,449 | 135 | Novartis Pharmaceuticals Corporation ($283.10) |
| 2021 | $3,335 | 145 | SANOFI-AVENTIS U.S. LLC ($600.00) |
| 2020 | $2,075 | 94 | SANOFI-AVENTIS U.S. LLC ($468.09) |
| 2019 | $2,750 | 149 | Novo Nordisk Inc ($278.26) |
| 2018 | $2,195 | 128 | Janssen Pharmaceuticals, Inc ($248.11) |
| 2017 | $2,806 | 148 | Novartis Pharmaceuticals Corporation ($345.70) |
All Payment Transactions
982 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Cardiology | ||||||
| 12/09/2024 | Azurity Pharmaceuticals, Inc. | EDARBI (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: VACCINE | ||||||
| 11/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: DIABETES | ||||||
| 11/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: Obesity | ||||||
| 10/31/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: NEUROLOGY | ||||||
| 10/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: VACCINES | ||||||
| 10/15/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Cardiology | ||||||
| 10/07/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Cardiology | ||||||
| 10/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.14 | General |
| Category: Cardiovascular | ||||||
| 09/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Obesity | ||||||
| 09/24/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Obesity | ||||||
| 09/12/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Heart Failure | ||||||
| 09/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Cardiology | ||||||
| 08/27/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 3,299 | 4,817 | $1.3M | $478,107 |
| 2022 | 22 | 3,222 | 4,611 | $1.2M | $467,676 |
| 2021 | 22 | 3,436 | 5,012 | $1.2M | $484,235 |
| 2020 | 26 | 3,638 | 5,234 | $1.2M | $449,275 |
Total Patients
13,595
Total Services
19,674
Medicare Billing
$1.9M
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 846 | 2,052 | $332,597 | $150,718 | 45.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 550 | 554 | $272,273 | $94,510 | 34.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 424 | 432 | $276,097 | $76,410 | 27.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 272 | 272 | $95,200 | $40,523 | 42.6% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 42 | 43 | $62,700 | $34,346 | 54.8% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 65 | 65 | $34,656 | $13,797 | 39.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 54 | 177 | $26,291 | $12,766 | 48.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 60 | 71 | $18,305 | $8,474 | 46.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 368 | 525 | $45,206 | $6,684 | 14.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 24 | 24 | $7,200 | $6,487 | 90.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 79 | 81 | $6,055 | $5,813 | 96.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 96 | 96 | $35,113 | $4,671 | 13.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 17 | 17 | $5,950 | $4,351 | 73.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 18 | 18 | $4,500 | $3,440 | 76.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $7,132 | $3,283 | 46.0% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 65 | 65 | $18,421 | $3,096 | 16.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 83 | 85 | $3,380 | $3,045 | 90.1% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 70 | 71 | $16,746 | $1,580 | 9.4% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 45 | 46 | $9,200 | $1,073 | 11.7% |
| 69200 | Removal of foreign body in ear canal | Office | 2023 | 12 | 13 | $1,625 | $999.38 | 61.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 29 | 29 | $1,015 | $960.40 | 94.6% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 12 | 12 | $3,543 | $670.80 | 18.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 16 | 17 | $340.00 | $259.52 | 76.3% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 16 | 16 | $1,440 | $150.92 | 10.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 772 | 1,816 | $292,882 | $135,940 | 46.4% |
About Dr. James Klepper, M.D
Dr. James Klepper, M.D is a Cardiovascular Disease healthcare provider based in Huntington, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043303233.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Klepper, M.D has received a total of $19,335 in payments from pharmaceutical and medical device companies, with $1,750 received in 2024. These payments were reported across 982 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($18,046).
As a Medicare-enrolled provider, Klepper has provided services to 13,595 Medicare beneficiaries, totaling 19,674 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Huntington, NY
- Active Since 10/02/2006
- Last Updated 04/25/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1043303233
Products in Payments
- MULTAQ (Drug) $1,612
- ENTRESTO (Drug) $1,170
- XARELTO (Drug) $1,124
- Vascepa (Drug) $829.75
- Repatha (Biological) $820.94
- LifeVest (Device) $726.84
- Corlanor (Drug) $681.14
- PRADAXA (Drug) $643.92
- JARDIANCE (Drug) $547.28
- Ozempic (Drug) $445.97
- Edarbi (Drug) $436.87
- NEXLETOL (Drug) $430.23
- ELIQUIS (Drug) $375.12
- LEQVIO (Drug) $369.61
- BELSOMRA (Drug) $351.03
- MitraClip System (Device) $315.25
- Wegovy (Drug) $290.87
- BRILINTA (Drug) $278.65
- WATCHMAN (Device) $264.49
- CARDIOMEMS (Device) $264.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Huntington
Dr. Paul Maccaro, Md, MD
Cardiovascular Disease — Payments: $63,935
Cardiovascular Disease $63,935
Dr. Esam Baryun, Md, MD
Cardiovascular Disease — Payments: $59,599
Cardiovascular Disease $59,599
Dr. Carlos Rueda Rios, M.d, M.D
Cardiovascular Disease — Payments: $53,004
Cardiovascular Disease $53,004
Nicholas Beccarino
Cardiovascular Disease — Payments: $44,554
Cardiovascular Disease $44,554
Dr. Paval Romano, M.d, M.D
Cardiovascular Disease — Payments: $22,952
Cardiovascular Disease $22,952
Skuli Gunnlaugsson, Md, MD
Cardiovascular Disease — Payments: $17,599
Cardiovascular Disease $17,599